Acetinolol (AC) is a β An adrenoceptor blocker used to treat hypertension, arrhythmia, or angina pectoris. The drug was approved by FDA in 1999, and many others β Receptor blockers are the same as drugs. At present, the drug is still administered in the form of mixed rotation.

Trestolone

MSDS

CAS:3764-87-2

Molecular Formula:C19H28O2

Alias

More Information

Ment; 19-Nor-7A-Methyltestosterone; 7Alpha-Methyl-19-Nortestosterone; 7Alpha-Methylnandrolone

Brief Introduction

As a progesterone derivative, trotolone has significantly better receptor sensitivity to male receptors than testosterone derivatives. Once it binds to androgen receptors, it will show strong protein synthesis ability. It can be used as pharmaceutical raw materials.

N-(2,3-Dihydro-1H-Inden-2-Yl)-N',N'-Diethyl-N-Phenyl-1,3-Propaned Iamine

MSDS

CAS:37640-71-4

Molecular Formula:C22H30N2

Alias

More Information

N-(2,3-Dihydro-1,5-Dimethyl-3-Oxo-2-Phenyl-1H-Pyrazol-4-Yl)-2-(Dimethylamino)Propionamide,Compound With 4-Butyl-1,2-Diphenylpyrazolidine-3,5-Dione (1:1); N'-(2,3-Dihydro-1H-Inden-2-Yl)-N,N-Diethyl-N'-Phenylpropane-1,3-Diamine

Brief Introduction

This product is an antiarrhythmic drug. Its hydrochloride is generally used, c22h30n2 · HCI = 358.96, amidal, fibocil, fiboran, [33273-74-0]. Its electrophysiological effect is similar to lidocaine. It is a myocardial cell membrane inhibitor with strong and lasting effect. It is suitable for the prevention and treatment of suffocating and suprasuffocating arrhythmias. Taking this product has side effects such as dizziness, tremor and insomnia. Mice were injected intraperitoneally with LD50 of 20mg / kg. The product is produced in the United States, Germany, Belgium and Australia, with simple preparation process and low cost.

S(+)-N,N-Diethyl-N'([8Alpha]-6-Methylergolin-8-Yl)Urea

MSDS

CAS:37686-84-3

Molecular Formula:C20H28N4O

Alias

More Information

Trans-Dihydro Lisuride; Dironyl; S(+)-Terguride; Trans-9,10-Dihydrolisuride Hydrogen Maleate; Terguride; Tdhl; 9,10A-Dihydrolisuride; Tergurid; 1,1-Diethyl-3-(6-Methyl-Ergolin-8-Yl)-Urea; Teluron; R-(+)-Terguride; (5R,8S,10R)-Terguride

Brief Introduction

Terguride (INN), is a serotonin receptor antagonist and dopamine receptor agonist of the ergoline family. It is approved for and used in the treatment of hyperprolactinemia. Terguride is an oral, potent antagonist of 5-HT2B and 5-HT2A (serotonin) receptors. Serotonin stimulates the proliferation of pulmonary artery smooth muscle cells, and induces fibrosis in the wall of pulmonary arteries. Together, this causes vascular remodeling and narrowing of the pulmonary arteries. These changes result in increased vascular resistance and PAH. Due to the potential anti-proliferative and anti-fibrotic activity of terguride, this potential medicine could offer the hope of achieving reversal of pulmonary artery vascular remodeling and attenuation of disease progression. In May 2008, terguride was granted orphan drug status for the treatment of pulmonary arterial hypertension. In May 2010 Pfizer purchased worldwide rights for the drug.

5-(3-Iodoprop-2-Ynoxy)-2-Methylsulfanylpyrimidine

MSDS

CAS:37750-83-7

Molecular Formula:C8H7IN2OS

Alias

More Information

Rimoproginum [Latin]; Rimoprogine [French]; Rimoprogina [Spanish]; Rimoproginum; 5-(3-Iodo-Prop-2-Ynyloxy)-2-Methylsulfanyl-Pyrimidine; Rimoprogine; Rimoprogina; Rimoprogin; Rimoprogin (Jan/Inn); 5-[(3-Iodo-2-Propynyl)Oxy]-2-(Methylthio)Pyrimidine; 2-Methylthio-5-(3-Jodopropargyloxy)Pyrimidin; Jaritin; Unii-Qg8198Sr7M

Brief Introduction

Rimoprogin is a pyrimidine derived compound with antifungal activity.

Inquiry (

/ 10

)

Clear All